Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from China Resources Pharmaceutical Group Ltd. ( (HK:3320) ).
China Resources Pharmaceutical Group Ltd. has appointed Mr. Wang Yuhang as a non-executive director, effective June 18, 2025. Mr. Wang brings extensive experience from various roles within China Resources Group and other organizations, enhancing the company’s leadership team. His appointment is expected to strengthen the company’s strategic direction and governance, although he will not receive any director’s emolument and holds no shares in the company.
The most recent analyst rating on (HK:3320) stock is a Buy with a HK$7.50 price target. To see the full list of analyst forecasts on China Resources Pharmaceutical Group Ltd. stock, see the HK:3320 Stock Forecast page.
More about China Resources Pharmaceutical Group Ltd.
China Resources Pharmaceutical Group Ltd. operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. It is part of the larger China Resources Group, which has diverse business units including environmental health and safety, and chemical innovative materials.
Average Trading Volume: 12,543,088
Technical Sentiment Signal: Buy
Current Market Cap: HK$33.55B
Learn more about 3320 stock on TipRanks’ Stock Analysis page.